PROJECT COMBINES NEW NEO-ANTIGEN PROFILING STRATEGIES COMBINED WITH HIGHLY BRAIN PENETRANT DRUGS FROM NON-TRADITIONAL CANCER DRUG PIPELINES TO DEVELOP IMMUNOTHERAPY/INHIBITOR COMBINATION TREATMENTS FOR GBM PATIENTS.

PIs: Timothy Cloughesy, M.D.
Director and Professor
Neuro-Oncology Program
University of California Los Angeles (UCLA)

James R. Heath, Ph.D.
Elizabeth W. Gilloon Professor
California Institute of Technology

Paul S. Mischel, M.D.
Member, Head and Professor
Laboratory of Molecular Pathology
Ludwig Institute for Cancer Research
University of California at San Diego

Close Menu